Skip to content
10-Q

Quarterly Report

UTAH MEDICAL PRODUCTS INC UTMD

0001096906-25-000816

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 12, 2025 3.25M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $83.33M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $82.98M
Stockholders Equity Q1 2025 · Mar 31, 2025 $117.05M
Stockholders Equity Q1 2025 · Dec 31, 2024 $117.43M
Current Liabilities Q1 2025 · Mar 31, 2025 $4.32M
Current Liabilities Q1 2025 · Dec 31, 2024 $3.76M
Total Liabilities Q1 2025 · Mar 31, 2025 $5.47M
Total Liabilities Q1 2025 · Dec 31, 2024 $5.11M
Current Assets Q1 2025 · Mar 31, 2025 $96.4M
Current Assets Q1 2025 · Dec 31, 2024 $96.33M
Total Assets Q1 2025 · Mar 31, 2025 $122.52M
Total Assets Q1 2025 · Dec 31, 2024 $122.54M
Shares Diluted Q1 2025 · Mar 31, 2024 3.62M sh
Stock Repurchased Q1 2025 · Mar 31, 2024 $2.99M
Dividends Paid Q1 2025 · Mar 31, 2024 $1.09M
Capex Q1 2025 · Mar 31, 2024 $22K
Operating Cash Flow Q1 2025 · Mar 31, 2024 $5.28M
Eps Diluted Q1 2025 · Mar 31, 2024 $1.09
Eps Basic Q1 2025 · Mar 31, 2024 $1.09
Sga Expense Q1 2025 · Mar 31, 2024 $2.62M
Rd Expense Q1 2025 · Mar 31, 2024 $266K
Net Income Q1 2025 · Mar 31, 2024 $3.96M
Operating Income Q1 2025 · Mar 31, 2024 $3.88M
Gross Profit Q1 2025 · Mar 31, 2024 $6.77M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $4.57M
Revenue Q1 2025 · Mar 31, 2024 $11.34M